Search for: "ABBVIE, INC."
Results 81 - 100
of 146
Sorted by Relevance
|
Sort by Date
12 Jul 2013, 2:00 pm
May 2013 Revised Depakote Drug Label Includes "Black-Box" And Warnings About These Congenital Malformations As Well As Decreased IQ Scores In Children (Posted by Tom Lamb at DrugInjuryWatch.com) As indicated below, in May 2013 there was a so-called "Black-Box" warning and several other significant label revisions about serious risks for children whose mother used the following anti-seizure medications during pregnancy which were added to the Prescribing Information by FDA and the drug company… [read post]
7 Mar 2019, 12:29 pm
One litigation that showcases the use and misuse of the ASA Statement arose from claims that AbbVie, Inc. [read post]
7 Dec 2018, 2:23 pm
TevaParenteral Meds., Inc., 689 F.3d 1368, 1376 (Fed. [read post]
6 Jun 2014, 1:18 pm
Lyon claims that AbbVie, Inc. and Abbott Laboratories withheld important information from patients and doctors about the risk of heart attacks and other blood clot injuries from Androgel use. [read post]
11 May 2020, 3:59 am
Drugmaker AbbVie Inc. has won U.S. antitrust approval to buy Botox maker Allergan, a blockbuster $63 billion deal when it was announced last year, the companies said on Tuesday. [read post]
1 Mar 2018, 2:35 pm
A third case was decided in AbbVie’s favor. [read post]
1 Mar 2018, 2:35 pm
A third case was decided in AbbVie’s favor. [read post]
16 Jul 2021, 12:53 pm
” AbbVie Deutschland GmbH & Co. v. [read post]
7 Jan 2015, 10:27 pm
In AbbVie Inc. v. [read post]
5 Aug 2014, 9:09 am
Studies Indicate Health Risks from Testosterone Therapy AndroGel is a topical testosterone-replacement medication produced and marketed by Abbott Laboratories and its AbbVie Inc. subsidiary. [read post]
23 Sep 2019, 6:31 am
Bristol-Myers Squibb’s $74 billion buyout of Celgene Corp. and AbbVie Inc. [read post]
1 Jul 2014, 6:16 am
Symptoms of low-T include: Loss of libido Decreased muscle mass Fatigue Products affected by the FDA request include AbbVie Inc’s AndroGel, Endo International Plc’s Aveed and Trimel Pharmaceuticals Corp’s Natesto. [read post]
17 Mar 2022, 2:32 pm
See Abbvie Deutschland GmbH & Co. v. [read post]
18 Apr 2016, 12:46 am
| Actavis v Lilly | EU public consultation on neighbouring rights | Life as an IP Lawyer in San Francisco | Copyright in chess games | Trade surplus and IP | Fujifilm Kyowa Biologics v AbbVie Biotechnology.Never too late 88 [week ending on Sunday 20 March] – CoA’s decision in Design & Display Limited v OOO Abbott & another | AG in McFadden C-484/14 on WiFi providers’ liability | Twitter on “Dronie” trade mark… [read post]
25 May 2018, 9:27 am
The case of Edwards Lifesciences LLC v Boston Scientific Scimed Inc & Ors [2018] EWHC 1256 (Pat) handed down yesterday, is a little more nuanced. [read post]
7 Apr 2020, 9:01 pm
Sandoz Inc. v. [read post]
30 Apr 2017, 4:30 am
Fujifilm v AbbVie: practice, procedure and policy analysisGuest Kat Eibhlin Vardy summarizes the Rapid Response event organized by AIPPI on the case Fujifilm Kyowa Kirin Biologics Company Limited v AbbVie Biotechnology Limited, [2017] EWHC 395 (Pat), from the perspective of patent and competition law.Overturning a trade mark opposition decision - Part 2 - SOULUXE - likelihood of confusionGuest Kat Rosie Burbidge recaps the case SoulCycle Inc v Matalan Ltd, [2017]… [read post]
16 Aug 2022, 8:00 am
Abbott Laboratories, Inc. and AbbVie, Inc., 2022 IL App (1st) 210478 (June 23, 2022). [read post]
28 Apr 2015, 9:14 am
AbbVie Inc. [read post]
1 Sep 2015, 9:19 am
The latest is a 2015 wrongful death suit filed in Illinois against the makers of AndroGel, AbbVie, Inc. [read post]
